Helmut Butzkueven (H Butzkueven)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Venues

Neurology

Therapeutic advances in neurological disorders

Scientific reports

European journal of neurology

Alfred Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alfred Hospital Jan 02 2018

Australia

Head, MS and Neuroimmunology Service :: Neurology

Monash University Central Clinical School Nov 15 2017

Australia

Chair of Multiple Sclerosis and Neuroimmunology Reseach :: Neuroscience

Publications

Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Francesca Bridge, Julia Brotherton, Jim Stankovich, Paul G Sanfilippo, Olga G Skibina, Katherine Buzzard, Tomas Kalincik, Ai-Lan Nguyen, Kylie Guo, Mastura Monif, C David Wrede, Louise Rath, Lisa Taylor, Helmut Butzkueven, Vilija G Jokubaitis, Anneke Van Der Walt
Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies. Neurology 102 (4) (2024)
Nicholas Riley, Susan Lavinia Greco, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van Der Walt, Erin O Y Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A Samjoo
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons. Therapeutic advances in neurological disorders 17 (2024)
Nicholas Riley, Susan Lavinia Greco, Morag Nelson, Anja Haltner, Michael Barnett, Simon Broadley, Helmut Butzkueven, Pamela McCombe, Anneke Van Der Walt, Erin O Y Wong, Martin Merschhemke, Nicholas Adlard, Rob Walker, Imtiaz A Samjoo
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons. Therapeutic advances in neurological disorders 17 (2024)
Jiwon Oh, Luca Capezzuto, Lito Kriara, Jens Schjodt-Eriksen, Johan van Beek, Corrado A Bernasconi, Xavier Montalban, Helmut Butzkueven, Ludwig Kappos, Gavin Giovannoni, Riley M Bove, Laura Julian, Michael Baker, Christian Gossens, Michael Lindemann
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Scientific reports 14 (1) (2024)
Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van Der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman, null null
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic advances in neurological disorders 17 (2024)
Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Jiwon Oh, Luca Capezzuto, Lito Kriara, Jens Schjodt-Eriksen, Johan van Beek, Corrado A Bernasconi, Xavier Montalban, Helmut Butzkueven, Ludwig Kappos, Gavin Giovannoni, Riley M Bove, Laura Julian, Michael Baker, Christian Gossens, Michael Lindemann
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Scientific reports 14 (1) (2024)
Francesca Bridge, Julia Brotherton, Jim Stankovich, Paul G Sanfilippo, Olga G Skibina, Katherine Buzzard, Tomas Kalincik, Ai-Lan Nguyen, Kylie Guo, Mastura Monif, C David Wrede, Louise Rath, Lisa Taylor, Helmut Butzkueven, Vilija G Jokubaitis, Anneke Van Der Walt
Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies. Neurology 102 (4) (2024)
Jiwon Oh, Luca Capezzuto, Lito Kriara, Jens Schjodt-Eriksen, Johan van Beek, Corrado A Bernasconi, Xavier Montalban, Helmut Butzkueven, Ludwig Kappos, Gavin Giovannoni, Riley M Bove, Laura Julian, Michael Baker, Christian Gossens, Michael Lindemann
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study. Scientific reports 14 (1) (2024)
Timothy Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Ozakbas, Rana Karabudak, Bassem I Yamout, Samia J Khoury, Murat Terzi, Cavit Boz, Dana Horakova, Eva Kubala Havrdova, Bianca Weinstock-Guttman, Francesco Patti, Ayse Altintas, Saloua Mrabet, Riadh Goudier, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W Luke Ward, Helmut Butzkueven, null null
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology 102 (7) (2024)
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van Der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman, null null
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies. Therapeutic advances in neurological disorders 17 (2024)
Richard Nicholas, Jeff Rodgers, James Witts, Annalaura Lerede, Tim Friede, Jan Hillert, Lars Forsberg, Anna Glaser, Ali Manouchehrinia, Ryan Ramanujam, Tim Spelman, Pernilla Klyve, Jiri Drahota, Dana Horakova, Hanna Joensen, Luigi Pontieri, Melinda Magyari, David Ellenberger, Alexander Stahmann, Helmut Butzkueven, Anneke Van Der Walt, Vladimir Bezlyak, Carol Lines, Rodden M Middleton
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe. Therapeutic advances in neurological disorders 16 (2023)
Alexandre Xavier, Vicki E Maltby, Ewoud Ewing, Maria Pia Campagna, Sean M Burnard, Jesper N Tegner, Mark Slee, Helmut Butzkueven, Ingrid Kockum, Lara Kular, null Ausimmune/AusLong Investigators Group, Vilija G Jokubaitis, Trevor Kilpatrick, Lars Alfredsson, Maja Jagodic, Anne-Louise Ponsonby, Bruce V Taylor, Rodney J Scott, Rodney A Lea, Jeannette Lechner-Scott
DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes. International journal of molecular sciences 24 (16) (2023)
Scott C Kolbe, L M Garcia, N Yu, Frederique Mc Boonstra, Meaghan Clough, Benjamin Sinclair, Owen B White, Anneke Van Der Walt, Helmut Butzkueven, Joanne Fielding, Meng Law
Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal Ganglia. AJNR. American journal of neuroradiology 43 (2) (2022)
Helmut Butzkueven, Paul S Giacomini, Stanley Cohan, Tjalf Ziemssen, Daniel Sienkiewicz, Ying Zhang, Yvonne Geissbühler, Diego Silva, Davorka Tomic, Harald Kropshofer, Maria Trojano
Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION-A 2-Year, Multicenter, Observational, Cohort Study. Brain sciences 12 (2) (2022)
Helmut Butzkueven, Ludwig Kappos, Tim Spelman, Maria Trojano, Heinz Wiendl, Ray Su, Shirley Liao, Robert Hyde, Stephanie Licata, Pei-Ran Ho, Nolan Campbell
No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP). Therapeutic advances in neurological disorders 14 (2021)
Helmut Butzkueven, Tim Spelman, Dana Horakova, Stella Hughes, Claudio Solaro, Guillermo Izquierdo, Eva Kubala Havrdová, Francois Grand'Maison, Alexandre Prat, Marc Girard, Raymond Hupperts, Marco Onofrj, Alessandra Lugaresi, Bruce Taylor, null null, Gavin Giovannoni, Ludwig Kappos, Stephen L Hauser, Xavier Montalban, Licinio Craveiro, Rita Freitas, Fabian Model, James Overell, Erwan Muros-Le Rouzic, Annette Sauter, Qing Wang, David Wormser, Jerry S Wolinsky
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. European journal of neurology (2021)
Vicki E Maltby, Rodney A Lea, Mastura Monif, Marzena J Fabis-Pedrini, Katherine Buzzard, Tomas Kalincik, Allan G Kermode, Bruce V Taylor, Suzanne Hodgkinson, Pamela A McCombe, Helmut Butzkueven, Michael Harry Barnett, Jeannette Lechner-Scott
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study). JMIR research protocols 10 (10) (2021)
Melissa M Gresle, Margaret A Jordan, Jim Stankovich, Tim Spelman, Laura J Johnson, Louise Laverick, Alison Hamlett, Letitia D Smith, Vilija G Jokubaitis, Josephine Baker, Jodi Haartsen, Bruce Taylor, Jac C Charlesworth, Melanie Bahlo, Terence P Speed, Matthew A Brown, Judith Field, Alan G Baxter, Helmut Butzkueven
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cells. Life science alliance 3 (7) (2020)

Helmut Butzkueven.css-eqlu8i{font-size:small;padding-left:4px;} (H Butzkueven)

Publication Activity (10 Years)

Top Topics

Top Venues

Helmut Butzkueven (H Butzkueven)